A simple method for producing a technetium-99m-labeled liposome which is stable in vivo.

A new method for labelling preformed liposomes with technetium-99m (99mTc) has been developed which is simple to perform and stable in vivo. Previous 99mTc-liposome labels have had variable labeling efficiencies and stability. This method consistently achieves high labeling efficiencies (greater than 90%) with excellent stability. A commercially available radiopharmaceutical kit--hexamethylpropyleneamine oxime (HM-PAO)--is reconstituted with 99mTcO4- and then incubated with preformed liposomes that encapsulate glutathione. The incubation takes only 30 min at room temperature. Liposomes that co-encapsulate other proteins such as hemoglobin or albumin, in addition to glutathione, also label with high efficiency. Both in vitro and in vivo studies indicate good stability of this label. Rabbit images show significant spleen and liver uptake at 2 and 20 h after liposome infusion without visualization of thyroid, stomach or bladder activity. This labeling method can be used to study the biodistribution of a wide variety of liposome preparations that are being tested as novel drug delivery systems. This method of labeling liposomes with 99mTc may also have applications in diagnostic imaging.

[1]  K. Gulenchyn,et al.  Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  R A Holmes,et al.  Technetium-99 m d , l-HM-PAO : A New Rathopharmaceutical for SPECT Imaging of Regional CerebralBlood Perfusion , 2006 .

[3]  V. Ferrans,et al.  Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. , 1990, Journal of the National Cancer Institute.

[4]  N. Lassen,et al.  The Retention Mechanism of Technetium-99m-HM-PAO: Intracellular Reaction with Glutathione , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  L. Williams,et al.  Technetium-labelled liposome imaging for deep-seated infection. , 1985, The British journal of radiology.

[6]  B D Williams,et al.  Effect of liposome surface charge on the stability of technetium (99mTc) radiolabelled liposomes. , 1989, Journal of microencapsulation.

[7]  B. Gaber,et al.  Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system. , 1987, Methods in enzymology.

[8]  V. Caride Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[9]  M. Tattersall,et al.  Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats. , 1977, Biochemical Society transactions.

[10]  S. Srivastava,et al.  Blood cell labeling with 99mTc: progress and perspectives. , 1990, Seminars in nuclear medicine.

[11]  J C Stewart,et al.  Colorimetric determination of phospholipids with ammonium ferrothiocyanate. , 1980, Analytical biochemistry.

[12]  A. Rudolph,et al.  The freeze-dried preservation of liposome encapsulated hemoglobin: a potential blood substitute. , 1988, Cryobiology.

[13]  M L Goris,et al.  In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  C. Presant,et al.  Successful imaging of human cancer with indium‐111‐labeled phospholipid vesicles , 1988, Cancer.

[15]  R. Perez-soler,et al.  Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's disease. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  E. Hersh,et al.  Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. , 1984, The Journal of infectious diseases.

[17]  T. N. Palmer,et al.  The mechanism of liposome accumulation in infarction. , 1984, Biochimica et biophysica acta.

[18]  A. Gottschalk,et al.  Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  B. Williams,et al.  Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis. , 1987, Annals of the rheumatic diseases.

[20]  K. Vandegriff,et al.  Liposome-encapsulated hemoglobin: oxygen binding properties and respiratory function. , 1988, Biomaterials, artificial cells, and artificial organs.

[21]  D. Sordelli,et al.  Enhanced liposome-mediated activity of piperacillin against staphylococci , 1985, Antimicrobial Agents and Chemotherapy.

[22]  W. Macklin,et al.  CHAPTER 3 – Anatomy, Physiology, and Biochemistry of the Rabbit , 1974 .

[23]  M. Tattersall,et al.  Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge, and liposome size. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.